Peripheral nervous system involvement in Sars-COV-2 infection
DOI:
https://doi.org/10.28957/rcmfr.v30spa13Keywords:
Coronavirus, Covid-19, Neurotropism, Sars-CoV-2, Neurological manifestations, Neurology, Neurologicalcomplications.Abstract
In December 2019 in China, one of the most complex pandemics of the last century begins, the Sars-CoV-2 or Covid-19 infection as it was named by the world health organization, is undoubtedly a public health emergency, that has required to implement modifications of the health systems in the world for its attention. Respiratory symptoms are the basis of the main complications of this infection, however relevant information on the neurological manifestations associated with Sars-CoV-2 is available, especially in relation to the compromise of the central nervous system (CNS); on the contrary, studies on the impact of the peripheral nerve are scarcer. The present review focuses on peripheral neurological manifestations associated with Covid-19.References
1. Organización Panamericana de la Salud [OPS] . Organización Mundial de la Salud (OMS). Covid-19 - Respuesta de la OPS/OMS, (1o. de junio de 2020) [Internet]. Washington: OPSOMS; 2020 [citado 2020 junio 25]. Reporte 10. Disponible en: https://www.paho.org/es/documentos/covid-19-respuesta-opsoms-reporte-10-1-junio-2020
2. Sun J, He W-T, Wang L, Lai A, Ji X, Zhai X, et al. Covid-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med. 2020;26(5):483-495. Disponible en: https://doi.org/10.1016/ j.molmed.2020.02.008
3. Ministerio de Salud y Protección Social - República de Colombia. Coronavirus (Covid-19). Reportes y Tableros de Control [Internet]. 2020 [citado 2020 junio 25]. Disponible en: https://www.minsalud.gov.co/salud/publica/PET/Paginas/Covid-19_copia.aspx
4. Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, Wang Q-Z, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (Covid-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29. Disponible en: https://doi.org/10.1186/s40249-020-00646-x
5. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of Sars-CoV-2: from neurological manifestations of Covid-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179-2184. Disponible en: https://dx.doi.org/10.1007%2Fs00415-020-09929-7
6. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol.2020;77(8):1018-1027. Disponible en: http://doi.org/10.1001/jamaneurol.2020.2065
7. Baig AM, Sanders EC. Potential Neuroinvasive Pathways of Sars-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (Covid-19). J Med Virol. 2020;92(10):1845-1857. Disponible en: https://doi.org/10.1002/jmv.26105h
8. Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of Covid-19: a review article. Neurol Sci. 2020;41(7):1667-1671. Disponible en: http://doi.org/10.1007/s10072-020-04486-3
9. Li H, Xue Q, Xu X. Involvement of the Nervous System in Sars-CoV-2 Infection. Neurotox Res. 2020;38(1):1-7. Disponible en: https://dx.doi.org/10.1007%2Fs12640-020-00219-8
10. Sheraton M, Deo N, Kashyap R, Surani S. A Review of Neurological Complications of Covid19. Cureus. 2020;12(5):e8192. Disponible en: https://dx.doi.org/10.7759%2Fcureus.8192
11. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. Disponible en: http://doi.org/10.1001/jamaneurol.2020.1127
12. Asadi-Pooya AA, Simani L. Central nervous system manifestations of Covid-19: A systematic review. J Neurol Sci. 2020;413:116832. Disponible en: https://dx.doi.org/10.1016%2Fj.jns.2020.116832
13. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (Covid-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-2261. Disponible en: https://doi.org/10.1007/s00405-020-05965-1h
14. Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in Covid-19 Patients. J Korean Med Sci. 2020;35(18):e174. Disponible en: https://dx.doi.org/10.3346%2Fjkms.2020.35.e174
15. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with Sars-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-384. Disponible en: https://doi.org/10.1016/s1474-4422(20)30109-5
16. Román GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, et al. The neurology of Covid-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. Disponible en: https://dx.doi.org/10.1016%2Fj.jns.2020.116884
17. Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of Covid-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020;194:105921. Disponible en: https://doi.org/10.1016/j.clineuro.2020.105921
18. Dubbioso R, Nobile-Orazio E, Manganelli F, Santoro L, Briani C, Cocito D, et al. Dealing with immune-mediated neuropathies during Covid-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP). Neurol Sci. 2020;41:1345-1348.
Disponible en: https://doi.org/10.1007/s10072-020-04448-9
19. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, GordoMañas R, et al. Miller Fisher Syndrome and polyneuritis cranialis in Covid-19. Neurology. 2020;95(5):e601-e605. Disponible en: https://doi.org/10.1212/WNL.0000000000009619
20. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA.
2020;323(11):1061-1069. Disponible en: https://dx.doi.org/10.1001%2Fjama.2020.1585
21. Jin M, Tong Q. Rhabdomyolysis as Potential Late Complication Associated with Covid-19. Emerg Infect Dis. 2020;26(7):1618-1620. Disponible en: https://doi.org/10.3201/eid2607.200445
22. Carod-Artal FJ. Complicaciones neurológicas por coronavirus y Covid-19. Rev Neurol; 2020;70(9):311-322. Disponible en: https://doi.org/10.33588/rn.7009.2020179
23. Das G, Mukherjee N, Ghosh S. Neurological Insights of Covid-19 Pandemic. ACS Chem Neurosci. 2020;11(9):1206-1209. Disponible en: https://doi.org/10.1021/acschemneuro.0c00201
24. Leonardi M, Padovani A, McArthur JC. Neurological manifestations associated with Covid-19: a review and a call for action. J Neurol. 2020;267(6):1573-1576. Disponible en: https://doi.org/10.1007/s00415-020-09896-z
25. Berardelli A, Silani V, Barone P, Calabresi P, Girlanda P, Lopiano L, et al. Neurology and the Covid-19 emergency. Neurol Sci. 2020;41(6):1343-1344. Disponible en: https://doi.org/10.1007/s10072-020-04465-8
26. Matías-Guiu J, Porta-Etessam J, Lopez-Valdes E, Garcia-Morales I, Guerrero-Solá A, Matias-Guiu JA. La gestión de la asistencia neurológica en tiempos de la pandemia de Covid-19. Neurología. 2020;35(4):233-237. Disponible en: https://dx.doi.org/10.1016%2Fj.nrl.2020.04.001
2. Sun J, He W-T, Wang L, Lai A, Ji X, Zhai X, et al. Covid-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med. 2020;26(5):483-495. Disponible en: https://doi.org/10.1016/ j.molmed.2020.02.008
3. Ministerio de Salud y Protección Social - República de Colombia. Coronavirus (Covid-19). Reportes y Tableros de Control [Internet]. 2020 [citado 2020 junio 25]. Disponible en: https://www.minsalud.gov.co/salud/publica/PET/Paginas/Covid-19_copia.aspx
4. Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, Wang Q-Z, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (Covid-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29. Disponible en: https://doi.org/10.1186/s40249-020-00646-x
5. Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of Sars-CoV-2: from neurological manifestations of Covid-19 to potential neurotropic mechanisms. J Neurol. 2020;267(8):2179-2184. Disponible en: https://dx.doi.org/10.1007%2Fs00415-020-09929-7
6. Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol.2020;77(8):1018-1027. Disponible en: http://doi.org/10.1001/jamaneurol.2020.2065
7. Baig AM, Sanders EC. Potential Neuroinvasive Pathways of Sars-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (Covid-19). J Med Virol. 2020;92(10):1845-1857. Disponible en: https://doi.org/10.1002/jmv.26105h
8. Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of Covid-19: a review article. Neurol Sci. 2020;41(7):1667-1671. Disponible en: http://doi.org/10.1007/s10072-020-04486-3
9. Li H, Xue Q, Xu X. Involvement of the Nervous System in Sars-CoV-2 Infection. Neurotox Res. 2020;38(1):1-7. Disponible en: https://dx.doi.org/10.1007%2Fs12640-020-00219-8
10. Sheraton M, Deo N, Kashyap R, Surani S. A Review of Neurological Complications of Covid19. Cureus. 2020;12(5):e8192. Disponible en: https://dx.doi.org/10.7759%2Fcureus.8192
11. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. Disponible en: http://doi.org/10.1001/jamaneurol.2020.1127
12. Asadi-Pooya AA, Simani L. Central nervous system manifestations of Covid-19: A systematic review. J Neurol Sci. 2020;413:116832. Disponible en: https://dx.doi.org/10.1016%2Fj.jns.2020.116832
13. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (Covid-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-2261. Disponible en: https://doi.org/10.1007/s00405-020-05965-1h
14. Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in Covid-19 Patients. J Korean Med Sci. 2020;35(18):e174. Disponible en: https://dx.doi.org/10.3346%2Fjkms.2020.35.e174
15. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with Sars-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383-384. Disponible en: https://doi.org/10.1016/s1474-4422(20)30109-5
16. Román GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, et al. The neurology of Covid-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. Disponible en: https://dx.doi.org/10.1016%2Fj.jns.2020.116884
17. Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of Covid-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020;194:105921. Disponible en: https://doi.org/10.1016/j.clineuro.2020.105921
18. Dubbioso R, Nobile-Orazio E, Manganelli F, Santoro L, Briani C, Cocito D, et al. Dealing with immune-mediated neuropathies during Covid-19 outbreak: practical recommendations from the task force of the Italian Society of Neurology (SIN), the Italian Society of Clinical Neurophysiology (SINC) and the Italian Peripheral Nervous System Association (ASNP). Neurol Sci. 2020;41:1345-1348.
Disponible en: https://doi.org/10.1007/s10072-020-04448-9
19. Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, GordoMañas R, et al. Miller Fisher Syndrome and polyneuritis cranialis in Covid-19. Neurology. 2020;95(5):e601-e605. Disponible en: https://doi.org/10.1212/WNL.0000000000009619
20. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA.
2020;323(11):1061-1069. Disponible en: https://dx.doi.org/10.1001%2Fjama.2020.1585
21. Jin M, Tong Q. Rhabdomyolysis as Potential Late Complication Associated with Covid-19. Emerg Infect Dis. 2020;26(7):1618-1620. Disponible en: https://doi.org/10.3201/eid2607.200445
22. Carod-Artal FJ. Complicaciones neurológicas por coronavirus y Covid-19. Rev Neurol; 2020;70(9):311-322. Disponible en: https://doi.org/10.33588/rn.7009.2020179
23. Das G, Mukherjee N, Ghosh S. Neurological Insights of Covid-19 Pandemic. ACS Chem Neurosci. 2020;11(9):1206-1209. Disponible en: https://doi.org/10.1021/acschemneuro.0c00201
24. Leonardi M, Padovani A, McArthur JC. Neurological manifestations associated with Covid-19: a review and a call for action. J Neurol. 2020;267(6):1573-1576. Disponible en: https://doi.org/10.1007/s00415-020-09896-z
25. Berardelli A, Silani V, Barone P, Calabresi P, Girlanda P, Lopiano L, et al. Neurology and the Covid-19 emergency. Neurol Sci. 2020;41(6):1343-1344. Disponible en: https://doi.org/10.1007/s10072-020-04465-8
26. Matías-Guiu J, Porta-Etessam J, Lopez-Valdes E, Garcia-Morales I, Guerrero-Solá A, Matias-Guiu JA. La gestión de la asistencia neurológica en tiempos de la pandemia de Covid-19. Neurología. 2020;35(4):233-237. Disponible en: https://dx.doi.org/10.1016%2Fj.nrl.2020.04.001
How to Cite
1.
Barrera Castro SM, Bonilla Díaz E, Vásquez Rojas MF. Peripheral nervous system involvement in Sars-COV-2 infection. Rev. Colomb. Med. Fis. Rehabil. [Internet]. 2020 Jul. 24 [cited 2024 May 18];30(Supl):162-70. Available from: https://revistacmfr.org/index.php/rcmfr/article/view/248
Downloads
Download data is not yet available.
